University of Colorado Health Eye Center
Welcome,         Profile    Billing    Logout  
 4 Trials 
14 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Preston, Mary
NCT05002998: TEPEZZA® (Teprotumumab-trbw) Post-Marketing Requirement Study

Active, not recruiting
4
313
Europe, US
Teprotumumab, TEPEZZA, Placebo, Saline Solution
Amgen
Thyroid Eye Disease
04/26
04/26
NCT04417530: Phase 2 Trial to Evaluate Belzupacap Sarotalocan (AU-011) Via Suprachoroidal Administration in Subjects With Primary Indeterminate Lesions and Small Choroidal Melanoma

Completed
2
22
US
AU-011, Suprachoroidal Microinjector, PDT Laser
Aura Biosciences
Uveal Melanoma, Ocular Melanoma, Choroidal Melanoma
04/24
04/24
NARROW, NCT05305079: NA-AION Risk Factors: New Perspectives

Completed
N/A
179
Europe, Canada, US, RoW
Rigshospitalet, Denmark, Velux Fonden, Fight for Sight, University of Copenhagen, Hamilton Health Sciences Corporation, Aarhus University Hospital, Aalborg University Hospital, Odense University Hospital, Farabi Eye Hospital, Wellington Hospital, University of Colorado, Denver, University of Utah, Lawson Health Research Institute, University of Sydney, Stanford University, Moorfields Eye Hospital NHS Foundation Trust, Massachusetts Eye and Ear Infirmary, University Hospital, Bordeaux, Synoptik-Fonden
Non-arteritic Ischemic Optic Neuropathy, Optic Disk Drusen
08/24
08/24
Zhu, Ping
TETON-PPF, NCT05943535: Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis

Recruiting
3
698
Canada, US, RoW
Placebo, Inhaled Treprostinil, Tyvaso, Treprostinil Ultrasonic Nebulizer
United Therapeutics
Progressive Pulmonary Fibrosis, Interstitial Lung Disease
11/27
11/27
REC-SAFECAD, NCT06572267: Safety and Efficacy of Meplazumab in Patients With Coronary Artery Disease

Recruiting
2
18
RoW
Mepolizumab low dose group, Mepolizumab middle dose group, Mepolizumab high dose group, Saline
Xijing Hospital
Coronary Artery Disease
09/25
03/26
NCT05293626: Gene Therapy Clinical Trial for the Treatment of Leber's Hereditary Optic Neuropathy Associated With ND4 Mutations

Active, not recruiting
1/2
12
US
NR082 Injection, Injection needle, Syringe
Neurophth Therapeutics Inc
Leber Hereditary Optic Neuropathy (LHON)
07/25
12/29
NCT06118320: The Effective of Potassium Sodium Hydrogen Citrate in Treating Uric Acid Stones Using Gut Microbiota and Metabolomics.

Recruiting
N/A
30
RoW
Potassium sodium hydrogen citrate, PSHC
Cheng Cao
Uric Acid Stones
03/24
06/24
CORN, NCT05339425: Chinese Osteoporotic Fracture Registration Network Platform

Recruiting
N/A
50000
RoW
No additional intervention will be administered.
Peking Union Medical College Hospital, Xuanwu Hospital, Beijing, Beijing Hospital, Tianjin First Central Hospital, Hebei Medical University Third Hospital, Dalian Hospital of Chinese Traditional and Western Medicine, The Second Affiliated Hospital of Harbin Medical University, Peking University Third Hospital, Beijing Shijingshan Hospital, The Second Medical Center of The General Hospital of the People's Liberation Army, Huamei hospital, University of Chinese Academy of Sciences, Second Affiliated Hospital, School of Medicine, Zhejiang University, Shanghai 10th People's Hospital, Ruijin Hospital, The First People's Hospital of Changzhou, Affiliated Hospital of Nantong University, Nantong First People's Hospital, Shanghai Changzheng Hospital, Wuhan Union Hospital, China, Central South University, Guangdong Provincial People's Hospital, Nanfang Hospital of Southern Medical University, Lunjiao Hospital of Shunde Foshan, The First Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine, First Affiliated Hospital of Fujian Medical University, Fuzhou Second Hospital, Second Affiliated Hospital of Guangzhou Medical University, Shenzhen Second People's Hospital, The Seventh Affiliated Hospital of Sun Yat-sen University, Sichuan Provincial People's Hospital, West China Fourth Hospital, Sichuan Province Orthopedic Hospital, The Second Affiliated Hospital of Chongqing Medical University, Daping Hospital, Army Medical Center of PLA, Guizhou Provincial Orthopedics Hospital, First Affiliated Hospital Xi'an Jiaotong University, Traditional Chinese Medicine Hospital of Xinjiang Uygur Autonomous Region, The First Affiliated Hospital of Zhengzhou University
Osteoporosis, Osteoporotic Fractures
12/24
12/24
Subramanian, Prem
NCT05002998: TEPEZZA® (Teprotumumab-trbw) Post-Marketing Requirement Study

Active, not recruiting
4
313
Europe, US
Teprotumumab, TEPEZZA, Placebo, Saline Solution
Amgen
Thyroid Eye Disease
04/26
04/26
THRIVE, NCT05176639 / 2021-006794-37: A Safety, Tolerability and Efficacy Study of Veligrotug (VRDN 001) in Healthy Volunteers and Participants with Thyroid Eye Disease (TED) ( )

Active, not recruiting
3
154
Europe, Canada, US, RoW
Veligrotug (VRDN-001) Phase 1/2 MAD (HV and TED), VRDN-001 Phase 3 Cohort (THRIVE), VRDN-001 Placebo
Viridian Therapeutics, Inc., Viridian Therapeutics, Inc.
Thyroid Eye Disease
07/24
03/25
NCT05293626: Gene Therapy Clinical Trial for the Treatment of Leber's Hereditary Optic Neuropathy Associated With ND4 Mutations

Active, not recruiting
1/2
12
US
NR082 Injection, Injection needle, Syringe
Neurophth Therapeutics Inc
Leber Hereditary Optic Neuropathy (LHON)
07/25
12/29
NCT05820152: Gene Therapy Clinical Trial for the Treatment of Leber's Hereditary Optic Neuropathy Associated With ND1 Mutations

Terminated
1/2
11
US, RoW
NFS-02 Injection
Neurophth Therapeutics Inc
Leber Hereditary Optic Neuropathy (LHON)
06/24
06/24
NARROW, NCT05305079: NA-AION Risk Factors: New Perspectives

Completed
N/A
179
Europe, Canada, US, RoW
Rigshospitalet, Denmark, Velux Fonden, Fight for Sight, University of Copenhagen, Hamilton Health Sciences Corporation, Aarhus University Hospital, Aalborg University Hospital, Odense University Hospital, Farabi Eye Hospital, Wellington Hospital, University of Colorado, Denver, University of Utah, Lawson Health Research Institute, University of Sydney, Stanford University, Moorfields Eye Hospital NHS Foundation Trust, Massachusetts Eye and Ear Infirmary, University Hospital, Bordeaux, Synoptik-Fonden
Non-arteritic Ischemic Optic Neuropathy, Optic Disk Drusen
08/24
08/24
ACON, NCT05605951: Acute Optic Neuritis Network: an International Study That Invesitages Subjects With a First-ever Episode of Acute Inflammation of the Optic Nerve

Recruiting
N/A
200
Europe, Japan, US, RoW
non-interventional study
Experimental and Clinical Research Center, a cooperation between the Max Delbrück Center for Molecul
Demyelinating Diseases, Multiple Sclerosis, Neuromyelitis Optica Spectrum Disorder Attack, Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease, Optic Neuritis
12/25
12/25

Download Options